PX1 Research supplies USA-synthesized, analytical-grade KPV tripeptide engineered strictly for in vitro, cellular, and animal model research. Every batch undergoes rigorous quality validation, including RP-HPLC purity verification, mass spectrometry, and endotoxin testing, ensuring reliable experimental reproducibility across all biomedical applications.
PX1 Research supplies USA-synthesized, analytical-grade KPV tripeptide engineered strictly for in vitro, cellular, and animal model research. Every batch undergoes rigorous quality validation, including RP-HPLC purity verification, mass spectrometry, and endotoxin testing, ensuring reliable experimental reproducibility across all biomedical applications.
Investigators looking to buy KPV peptide online for scientific investigation require absolute purity, structural fidelity, and rigorous batch-to-batch consistency. KPV is a C-terminal tripeptide fragment (Lysine-Proline-Valine) derived from alpha-melanocyte-stimulating hormone (α-MSH). In preclinical settings, it is studied extensively for its ability to modulate intracellular inflammatory cascades without engaging classical melanocortin receptors that trigger pigmentary responses.
When sourcing high-purity KPV tripeptide, academic institutions, biotechnology enterprises, and clinical laboratories must prioritize vendors that maintain full supply-chain transparency. PX1 Research synthesizes KPV within USA-based, GMP-compliant facilities. Every lot is verified by an independent ISO 17025 accredited laboratory to guarantee a purity profile exceeding 98% by reverse-phase high-performance liquid chromatography (RP-HPLC) and electrospray ionization mass spectrometry (ESI-MS). Qualified laboratories can access our complete catalog of research peptides to support multidisciplinary investigation.
KPV is a small bioactive tripeptide composed of L-lysine, L-proline, and L-valine residues with the chemical formula C16H30N4O4 and a molecular weight of approximately 342.44 g/mol. Derived from the C-terminal sequence of α-MSH (residues 11–13), KPV retains the core anti-inflammatory properties of its parent proopiomelanocortin (POMC) derivative while lacking the amino acid sequences necessary for melanocortin receptor 1 (MC1R) or melanocortin receptor 4 (MC4R) activation responsible for pigmentation and central appetite modulation.
Because of its low molecular weight and amphipathic nature, KPV exhibits distinct pharmacokinetic properties in tissue models. Unlike larger polypeptide chains that require specific active transport mechanisms or are rapidly degraded by luminal endopeptidases, KPV displays enhanced stability in specialized buffer systems. Researchers frequently utilize KPV in molecular assays targeting intracellular signal transduction, nuclear receptor import mechanisms, and localized cellular responses in epithelial barriers.
The primary mechanism of action documented in KPV scientific literature centers on its interaction with the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling pathway. NF-κB functions as a primary transcription factor regulating the expression of pro-inflammatory cytokines, chemokines, and adhesion molecules. Preclinical studies indicate that KPV enters the cytoplasm and nucleus via PepT1 transporter-mediated uptake or direct cellular permeation, where it physically interacts with nuclear factor subunits.
In vitro assays using reporter gene constructs demonstrate that KPV directly inhibits the translocation of the NF-κB p65 subunit into the nucleus following stimulation by lipopolysaccharide (LPS) or tumor necrosis factor-alpha (TNF-α). By blocking nuclear entry, KPV downregulates the transcription of key pro-inflammatory mediators, including interleukin-1 beta (IL-1β), interleukin-6 (IL-6), interleukin-8 (IL-8), and inducible nitric oxide synthase (iNOS). Investigators utilizing our peptide research hub can explore detailed mechanistic pathways involving signaling cascades in cellular models.
A substantial portion of published research on KPV focuses on mucosal immunity and intestinal epithelial integrity. In murine models of experimental colitis—such as dextran sulfate sodium (DSS)-induced or 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced inflammatory bowel disease (IBD)—the administration of KPV demonstrated significant attenuation of histological damage, mucosal ulceration, and myeloperoxidase (MPO) activity.
Mechanistic animal studies suggest that KPV preserves the structural integrity of tight junction complexes within the gut epithelium. In vitro monolayer assays utilizing Caco-2 and HT-29 human intestinal cell lines reveal that KPV treatment prevents the redistribution and loss of key barrier proteins, including zonula occludens-1 (ZO-1), occludin, and claudin family members. By dampening localized mucosal inflammation and upregulating protective mucin production, KPV serves as a valuable molecular tool for investigating epithelial restitution and mucosal wound healing.
Beyond its classical anti-inflammatory capabilities, KPV exhibits intrinsic antimicrobial and fungicidal properties in preclinical assays. In vitro microbiology models have shown that KPV possesses direct inhibitory action against pathogenic microorganisms, notably *Candida albicans* and *Staphylococcus aureus*. The tripeptide disrupts microbial cell membranes and inhibits germ tube formation in fungal species at micromolar concentrations.
This dual action—simultaneously dampening hyper-inflammatory host signaling while inhibiting opportunistic microbial proliferation—makes KPV a unique candidate in dermatological, mucosal, and biomaterial surface research. Laboratories conducting antimicrobial assays or co-culture barrier experiments frequently integrate anti-inflammatory research peptides like KPV to evaluate cytoprotective mechanisms against bacterial enterotoxins.
When purchasing synthetic tripeptides online, analytical rigor is essential to prevent confounding experimental variables caused by residual synthesis reagents, truncated sequences, or bacterial contamination. PX1 Research adheres to stringent quality assurance protocols to ensure every vial meets or exceeds laboratory standards:
1. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC): Determines peptide purity and confirms the absence of closely related synthesis impurities or deletion sequences. Every lot must achieve ≥98.0% purity. 2. Electrospray Ionization Mass Spectrometry (ESI-MS): Verifies exact monoisotopic molecular mass and structural identity, confirming correct peptide synthesis. 3. Endotoxin Quantitation (LAL Assay): Measures bacterial endotoxin levels. For cellular culture and sensitive in vivo assays, endotoxin levels are maintained below <0.01 EU/mg to eliminate background immune activation. 4. Residual Solvent and Moisture Analysis: Thermogravimetric analysis ensures full removal of volatile organic solvents (such as trifluoroacetic acid, or TFA) used during cleavage and purification.
Investigators can review independent, lot-specific Certificates of Analysis (COAs) directly prior to procurement, ensuring complete transparency and compliance for peer-reviewed research.
Understanding how KPV compares to other mucosal integrity research peptides is vital when designing comparative preclinical experiments. While KPV specifically targets nuclear NF-κB translocation, compounds such as BPC-157 peptide operate predominantly through upregulating vascular endothelial growth factor (VEGF) expression, accelerating focal adhesion kinase (FAK) signaling, and modulating nitric oxide pathways to promote tissue repair.
Similarly, larazotide acetate acts directly as a tight junction regulator by antagonizing zonulin receptors, preventing microfilament reorganization without exhibiting direct broad-spectrum anti-inflammatory or antimicrobial properties. In contrast, KPV offers a unique intersection of cytokine suppression, intracellular nuclear signal blockade, and direct antimicrobial activity. Integrating these distinct chemical tools allows researchers to evaluate overlapping pathways in complex tissue co-culture models.
KPV is supplied as a sterile, lyophilized (freeze-dried) powder to maximize chemical stability during transport and storage. Proper laboratory reconstitution is necessary to maintain bioactivity and prevent peptide aggregation or premature degradation in working stock solutions.
To reconstitute KPV for laboratory use, sterile Bacteriostatic Water, Phosphate-Buffered Saline (PBS, pH 7.4), or endotoxin-free cell culture grade water should be added under laminar flow conditions. KPV demonstrates high solubility in aqueous buffer systems due to the polar lysine residue. Reconstitution should be performed by gently swirling the vial; vigorous vortexing or sonication should be avoided to prevent mechanical shear stress. For cell culture experiments requiring specific vehicle controls, stock concentrations ranging from 1 mM to 10 mM can be prepared, aliquoted into single-use polypropylene microtubes, and frozen immediately to avoid repeated freeze-thaw cycles.
To ensure long-term stability and structural integrity, lyophilized KPV powder should be stored in a dry, dark environment at -20°C or -80°C upon receipt. Under these conditions, the unconstitutionally stable tripeptide remains stable for up to 24 months. Desiccants should be maintained within the storage container to prevent atmospheric moisture absorption.
Once reconstituted into an aqueous stock solution, KPV should be stored at 4°C for short-term use (not exceeding 7–10 days) or divided into single-use aliquots and maintained at -80°C for extended storage (up to 6 months). Avoid storing solutions in frost-free freezers, as temperature fluctuations during automatic defrost cycles lead to peptide denaturation. All shipments from PX1 Research originate from our CA and AZ facilities with insulated packaging to preserve thermal integrity during transit.
PX1 Research caters to academic laboratories, government research institutions, contract research organizations (CROs), and industrial R&D facilities requiring custom quantities or bulk supply. Through our dedicated wholesale laboratory account portal, procurement managers can access volume tiering, custom vial filling, and dedicated account support.
Orders placed before 12:00 PM PST Monday through Friday ship same-day from our California and Arizona logistics hubs. Every shipment is accompanied by batch-specific documentation, safety data sheets (SDS), and comprehensive analytical validation, establishing PX1 Research as the definitive domestic supplier for high-purity KPV tripeptide.
What analytical testing confirms KPV tripeptide purity at PX1 Research?
Every lot of KPV tripeptide undergoes mandatory high-performance liquid chromatography (RP-HPLC) to verify purity levels of ≥98.0%, mass spectrometry (ESI-MS) for mass verification, and Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain below strictly controlled research thresholds (<0.01 EU/mg).
How does KPV compare to full-length alpha-MSH in preclinical models?
KPV represents the C-terminal tripeptide (amino acids 11–13) of alpha-MSH. While full-length alpha-MSH activates melanocortin receptors (MC1R–MC5R) leading to skin pigmentation and central metabolic signaling, KPV bypasses classical melanocortin receptor activation, exerting anti-inflammatory effects primarily through intracellular PepT1 transport and NF-κB suppression.
What standard reconstituting solvents are recommended for KPV in cell culture?
KPV is highly soluble in aqueous solutions. Recommended reconstituting media include sterile endotoxin-free water, sterile Phosphate-Buffered Saline (PBS, pH 7.4), or cell culture media. For sterile cellular assays, stock solutions should be filtered through a 0.22-micron low-protein-binding membrane.
What are the documented endotoxin limits for PX1 Research KPV?
PX1 Research guarantees endotoxin levels <0.01 EU/mg for all research-grade KPV lots. Low endotoxin levels are vital for in vitro macrophage, enterocyte, and animal models to prevent spurious immune activation from lipopolysaccharide contamination.
How should lyophilized KPV be stored upon receipt in the laboratory?
Lyophilized KPV powder should be stored at -20°C or -80°C in a dry location protected from light. Under these conditions, the peptide remains stable for up to 24 months. Reconstituted aliquots should be frozen at -80°C to avoid degradation.
Can KPV be integrated into Caco-2 epithelial transport assays?
Yes. KPV is widely referenced in literature utilizing Caco-2 and HT-29 monolayer transport models to evaluate intestinal permeability, PepT1 transport kinetics, tight junction regulation, and inflammatory cytokine suppression.
What documentation is provided with PX1 Research orders?
Every order includes a lot-specific Certificate of Analysis (COA) containing the HPLC chromatogram, mass spectrometry spectrum, endotoxin test report, along with a Safety Data Sheet (SDS) and handling guidelines for laboratory personnel.
What shipping options and dispatch locations are used for KPV orders?
PX1 Research dispatches orders same-day Monday through Friday (for orders placed prior to 12:00 PM PST) from our distribution hubs in California and Arizona. Packages are shipped in temperature-controlled, insulated packaging to protect compound integrity.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.